Laumas Sandeep 4
4 · BioXcel Therapeutics, Inc. · Filed Jun 15, 2021
Insider Transaction Report
Form 4
Laumas Sandeep
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-11+14,500→ 14,500 totalExercise: $37.86Exp: 2031-06-11→ Common Stock (14,500 underlying)
Footnotes (1)
- [F1]The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date.